Behavioral Pharmacology of Drug Abuse: Current Status
- 1st Edition, Volume 93 - March 10, 2022
- Imprint: Academic Press
- Editor: Jun-Xu Li
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 9 1 5 2 6 - 7
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 9 1 5 2 7 - 4
Behavioral Pharmacology of Drug Abuse: Current Status, Volume 93 provides an update on our current understanding of animal and human behavioral pharmacology in major classes o… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteBehavioral Pharmacology of Drug Abuse: Current Status, Volume 93 provides an update on our current understanding of animal and human behavioral pharmacology in major classes of drugs of abuse, including nicotine, alcohol, opioids, psychostimulants, and hallucinogens, drug-environment interactions, neurochemical mechanisms and medications developments. This volume updates the field of behavioral pharmacology based on new knowledge gained in the past decade.
- Provides accurate and updated reviews from selected experts on covered topics
- Presents useful graphic material for ease of reading
- Covers a wide range of topics that are highly integral to offer a panoramic view of the field of behavioral pharmacology
Pharmacologists, medicinal chemists and graduate students who are interested in behavioral neuropharmacology of drug abuse
- Cover
- Title page
- Table of Contents
- Copyright
- Contributors
- Preface
- Chapter One: Interactions between opioids and stimulants: Behavioral pharmacology of abuse-related effects
- Abstract
- 1: Introduction
- 2: Abuse-related effects of opioid/stimulant combinations
- 3: Conclusion
- References
- Chapter Two: In vitro and in vivo pharmacology of kratom
- Abstract
- 1: Introduction
- 2: Pharmacodynamics of kratom alkaloids in vitro
- 3: Pharmacokinetics of kratom alkaloids
- 4: Behavioral effects of kratom alkaloids
- 5: Conclusion
- References
- Chapter Three: Human behavioral pharmacology of stimulant drugs: An update and narrative review
- Abstract
- 1: Introduction
- 2: Human behavioral pharmacology of cocaine
- 3: Human behavioral pharmacology of amphetamine
- 4: Conclusion
- References
- Chapter Four: Human behavioral pharmacology of psychedelics
- Abstract
- 1: Introduction
- 2: Classic psychedelics
- 3: Special considerations
- 4: Psilocybin
- 5: LSD
- 6: DMT
- 7: Conclusion
- References
- Chapter Five: Stimulus functions of nicotine
- Abstract
- 1: Introduction
- 2: Stimulus functions of nicotine
- 3: Role of stimulus functions in tobacco use theory
- 4: Conclusion
- References
- Chapter Six: The incentive amplifying effects of nicotine: Roles in alcohol seeking and consumption
- Abstract
- 1: Introduction
- 2: Appetitive effects of nicotine
- 3: Consummatory effects of nicotine
- 4: Neurobiological underpinnings of nicotine's reinforcing and incentive amplifying effects
- 5: Conclusion
- References
- Chapter Seven: Environmental influence on the preclinical evaluation of substance use disorder therapeutics
- Abstract
- 1: Introduction
- 2: Drug dependence and withdrawal on candidate medication effectiveness
- 3: Schedule-related variables on candidate medication effectiveness
- 4: Subject housing variables on candidate medication effectiveness
- 5: Subject variables on candidate medication effectiveness
- 6: Conclusion
- References
- Chapter Eight: Examining the effects of psychoactive drugs on complex behavioral processes in laboratory animals
- Abstract
- 1: Introduction
- 2: Cognitive tasks in pharmacology
- 3: Caveats and considerations
- 4: On terms coda
- 5: Conclusion
- References
- Chapter Nine: Receptor mechanisms underlying the CNS effects of cannabinoids: CB1 receptor and beyond
- Abstract
- 1: Introduction
- 2: Cannabinoid receptors
- 3: Cannabinoid tetrad effects
- 4: Cannabinoid subjective effects
- 5: Cannabinoid effects on anxiety
- 6: Cannabinoid cognitive effects
- 7: Conclusion
- References
- Chapter Ten: Potential therapeutic targets for the treatment of opioid abuse and pain
- Abstract
- 1: Introduction
- 2: Opioid abuse
- 3: Pain
- 4: Treatment of pain by spinal and supraspinal actions
- 5: Conclusions
- References
- Chapter Eleven: Trace amine-associated receptor 1 and drug abuse
- Abstract
- 1: Introduction
- 2: The implication of TAAR1 in the brain
- 3: Neural mechanisms of TAAR1 in drug addiction
- 4: TAAR1 and psychostimulants
- 5: TAAR1 and opioids
- 6: TAAR1 and alcohol
- 7: Current challenges
- 8: Conclusion
- References
- Chapter Twelve: Substance abuse and neurotransmission
- Abstract
- 1: Introduction
- 2: Cocaine
- 3: Methamphetamine
- 4: Amphetamine
- 5: Opioids
- 6: Alcohol
- 7: Nicotine
- 8: Drugs of abuse and HIV-1
- 9: Considerations regarding COVID-19
- 10: Conclusion
- References
- Edition: 1
- Volume: 93
- Published: March 10, 2022
- Imprint: Academic Press
- No. of pages: 456
- Language: English
- Hardback ISBN: 9780323915267
- eBook ISBN: 9780323915274
JL
Jun-Xu Li
Jun-Xu Li received his MD degree at Binzhou Medical University in 2o0o; In 2005 he received his Ph.D in pharmacology at Peking University. He received his postdoctoral training between 2005-2010 at the University of Texas Health Science Center at San Antonio. In 2010 he joined the faculty of Department of Pharmacology and Toxicology at the State University of New York at Buffalo and is currently a professor in the same department. He has authored more than 120 papers and is currently an associate editor of Pharmacology & Therapeutics. He serves as an reviewer for numerous scientific journals and several grant agencies. He is the past chair of Behavioral Pharmacology Division of American Society of Pharmacology and Experimental Therapeutics (ASPET) and Upstate New York Pharmacology Society. He received several awards including the Joseph Cochin Young Investigator Award from the College on Problems of Drug Dependence and the JH Woods Early Career Award in Behavioral Pharmacology from ASPET.
Affiliations and expertise
University at Buffalo, Buffalo, New York, USARead Behavioral Pharmacology of Drug Abuse: Current Status on ScienceDirect